No black box warning on record for Atovaquone And Proguanil Hydrochloride Pediatric

As of the latest FDA labeling reviewed, Atovaquone And Proguanil Hydrochloride Pediatric (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC) does not carry a black box warning. Standard warnings and precautions still apply — see the full Atovaquone And Proguanil Hydrochloride Pediatric medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Atovaquone absorption may be reduced in patients with diarrhea or vomiting. If used in patients who are vomiting, parasitemia should be closely monitored and the use of an antiemetic considered. In patients with severe or persistent diarrhea or vomiting, alternative antimalarial therapy may be required. ( 5.1 ) • In mixed P. falciparum and Plasmodium vivax infection, P

No black box warning on record for Atovaquone And Proguanil Hydrochloride Pediatric

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Atovaquone absorption may be reduced in patients with diarrhea or vomiting. If used in patients who are vomiting, parasitemia should be closely monitored and the use of an antiemetic considered. In patients with severe or persistent diarrhea or vomiting, alternative antimalarial therapy may be required. ( 5.1 ) • In mixed P. falciparum and Plasmodium vivax infection, P

Atovaquone And Proguanil Hydrochloride Pediatric Black Box Warning

No black box warning on record for Atovaquone And Proguanil Hydrochloride Pediatric

Other warnings & precautions

Atovaquone And Proguanil Hydrochloride Pediatric Black Box Warning

No black box warning on record for Atovaquone And Proguanil Hydrochloride Pediatric

Other warnings & precautions